Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 7 studies | 19% ± 2% | |
myofibroblast cell | 5 studies | 21% ± 3% | |
epithelial cell | 4 studies | 31% ± 12% | |
fibroblast | 4 studies | 17% ± 1% | |
pericyte | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of TEAD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 8093.20 | 245 / 245 | 100% | 65.48 | 502 / 502 |
uterus | 100% | 10736.66 | 170 / 170 | 100% | 86.94 | 458 / 459 |
ovary | 100% | 4946.98 | 180 / 180 | 100% | 77.72 | 429 / 430 |
esophagus | 100% | 9813.16 | 1445 / 1445 | 99% | 69.71 | 182 / 183 |
intestine | 100% | 10058.03 | 966 / 966 | 99% | 52.76 | 522 / 527 |
lung | 99% | 4153.95 | 575 / 578 | 99% | 59.80 | 1149 / 1155 |
bladder | 100% | 10070.43 | 21 / 21 | 98% | 80.56 | 495 / 504 |
stomach | 99% | 5122.51 | 355 / 359 | 99% | 53.57 | 282 / 286 |
breast | 96% | 3416.48 | 442 / 459 | 99% | 51.94 | 1110 / 1118 |
thymus | 99% | 2897.21 | 647 / 653 | 94% | 38.18 | 571 / 605 |
skin | 100% | 5693.55 | 1807 / 1809 | 81% | 23.35 | 382 / 472 |
kidney | 97% | 2634.58 | 86 / 89 | 82% | 17.85 | 741 / 901 |
liver | 84% | 1456.42 | 189 / 226 | 86% | 22.99 | 351 / 406 |
pancreas | 31% | 481.98 | 102 / 328 | 97% | 58.87 | 173 / 178 |
adrenal gland | 59% | 894.76 | 152 / 258 | 44% | 7.36 | 101 / 230 |
blood vessel | 100% | 8343.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 69.51 | 1 / 1 |
adipose | 99% | 2940.33 | 1187 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 2607.16 | 785 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 25.69 | 78 / 80 |
heart | 95% | 3311.56 | 819 / 861 | 0% | 0 | 0 / 0 |
spleen | 83% | 1673.07 | 199 / 241 | 0% | 0 | 0 / 0 |
brain | 2% | 26.03 | 50 / 2642 | 27% | 6.18 | 193 / 705 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.35 | 1 / 29 |
peripheral blood | 0% | 5.09 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055059 | Biological process | asymmetric neuroblast division |
GO_0048568 | Biological process | embryonic organ development |
GO_0007565 | Biological process | female pregnancy |
GO_0035329 | Biological process | hippo signaling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | TEAD3 |
Protein name | TEAD3 protein TEA domain transcription factor 3 Transcriptional enhancer factor TEF-5 Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3) (TEAD-3) |
Synonyms | TEF5 TEAD5 |
Description | FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer. . FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. . FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. . |
Accessions | Q96G15 ENST00000338863.13 A0A1X7SBS4 A0A7P0SNI2 B5MCM0 ENST00000338863 ENST00000639578.3 ENST00000402886.9 Q99594 |